[18f]fluorothymidine and [18f]fluorodeoxyglucose pet imaging demonstrates uptake and differentiates growth in neurofibromatosis 2 related vestibular schwannoma

Vascular biomarkers derived from dynamic contrast-enhanced mri predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis

Disease course of neurofibromatosis type 2; a 30-year follow-up study of 353 patients seen at a single institution

High-grade glioma is not a feature of neurofibromatosis type 2 in the unirradiated patient

Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis type 2

Bilateral vestibular schwannomas in older patients: nf2 or chance?

Petrous bone cholesteatoma: the manchester experience

Dwi imaging in extensive petrous bone cholesteatoma